스텐트연구소 > 논문 > Drug-eluting stent as an option for intractable in-stent coronary restenosis.

임상

작성일 : 16-03-14 00:58


논문번호	107

논문제목(영문)	Drug-eluting stent as an option for intractable in-stent coronary restenosis.

국내외구분	국내	SCI여부	SCI(E)

연구책임자역할	교신저자

주저자명	Hachinohe D

교신저자명	Jeong MH

공동저자명	Hachinohe D, Jeong MH, Kim MC, Cho KH, Ahmed K, Hwang SH, Lee MG, Sim DS, Park KH, Kim JH, Hong YJ, Ahn Y, Kang JC;

게제년월일	2011-02-16

ISSN	1738-5520

Impact Factor	0.753

학술지명	Korean Circ J

서지사항	0집 / 41권 / 11호, 페이지(677 - 680)

요약초록문 (Abstract) 입력	A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. After thrombolytic therapy using recombinant tissue plasminogen activator, stent implantation was performed from the proximal left anterior descending artery (LAD) to the mid LAD using a bare-metal stent (BMS). Since then, the patient suffered five repeated episodes of in-stent restenosis (ISR). At the first ISR, he was treated with plain old balloon angioplasty (POBA). At the second ISR, he was treated with brachytherapy, and at the third ISR, he was treated with POBA and one more BMS distal to the previously implanted stent. At the forth, only POBA was performed, and finally, at the fifth ISR, a sirolimus-eluting stent was implanted. Following that, the patient remained asymptomatic and follow-up coronary angiography showed no ISR.

파일	C107.+Korean+Circ+J.+2011;41(11)677-680..pdf (639.5K) DATE : 2021-05-25 14:31:18